Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00121069
Status:
COMPLETED
Last Update Posted:
2005-07-21
First Post:
2005-07-13
Brief Title:
Study of Escitalopram in the Treatment of Specific Phobia
Sponsor:
Connor Kathryn M MD
Organization:
Connor Kathryn M MD
Study Overview
Official Title:
Placebo-Controlled Pilot Study of Escitalopram in the Treatment of Specific Phobia
Status:
COMPLETED
Status Verified Date:
2005-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This pilot study is designed to assess the efficacy of escitalopram in the treatment of specific phobia in adult outpatients
Detailed Description:
This double-blind placebo-controlled pilot trial study is designed to assess the efficacy of 12 weeks of escitalopram vs placebo in the treatment of specific phobia in adult outpatients It is hypothesized that escitalopram is safe and effective in the treatment of specific phobia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None